Table 2.
Comparison of peripheral variables of the severe adult with critical adult patients.
| Variables | S.Ad = 12n | C.Ad = 17 n | P -value | ||
|---|---|---|---|---|---|
| Male = 9n (75%) | Female = 3n (25%) | Male = 8n (47.1%) | Female = 9n (52.9%) | ||
| Median (IQR) | Mean ± SD | Median (IQR) | Mean ± SD | ||
| Age, years | 59.33 ± 17.35 | 63.76 ± 14.55 | Φ 0.462 | ||
| Laboratory findings | |||||
| WBC (109/L) | 5.85 (4.3) | 10.40 (12) | Ω 0.000*** | ||
| Lym (109/L) | 21.00 (11.5) | 18.00 (23) | Ω 0.047* | ||
| NLR | 13.20 (6) | 14.30 (13.20) | Ω 0.042* | ||
| CRP (mg/L) | 31.50 (50) | 87.50 (46) | Ω 0.046* | ||
| D-Dimer (μg/ml) | 1.10 (1.03) | 2.90 (3.70) | Ω 0.010* | ||
| Neu (109/L) | 72.50 ± 7.66 | 89.13 ± 9.75 | Φ 0.063 | ||
| CD4+/CD8+ ratio | 1.04 (0.43) | 2.00 (1.15) | Ω 0.003** | ||
| CD19+ B cell (%) | 9.50 (6) | 11.00 (25) | Ω 0.128 | ||
| CD14+ monocyte (%) | 5.50 (2.3) | 5.00 (7.0) | Ω 0.146 | ||
| CD3+ Total T lymphocyte (%) | 70.17 ± 9.36 | 55.69 ± 11.85 | Φ 0.002** | ||
| CD3+CD4+ T cell (%) | 50.83 ± 10.88 | 62.00 ± 11.05 | Φ 0.012* | ||
| CD3+CD8+ T cell (%) | 42.25 ± 9.56 | 28.59 ± 9.17 | Φ 0.001** | ||
| CD16+CD56+ Nk cell (%) | 6.67 ± 5.18 | 10.82 ± 8.81 | Φ 0.155 | ||
Data are presented as median (IQR) and mean ± SD.
COVID-19, coronavirus 2019; S.Ad, severe adult; C.Ad, critical adult; WBC, white blood cell; Neu, neutrophil; Lym, lymphocyte; NLR, neutrophil to lymphocyte ratio; CRP, c-reactive protein; D-Dimer, a fibrin degradation product or FDP. Ω, Mann–Whitney U; Φ, T-test.
*
p < 0.05;
**
p < 0.01;
***
p < 0.001.